Arhalofenate
Sponsors
Gilead Sciences
Conditions
GoutHyperuricemia
Phase 2
Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout
CompletedNCT01336686
Start: 2011-05-01End: 2011-11-01Updated: 2026-09-18
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
CompletedNCT01399008
Start: 2011-06-30End: 2012-02-29Updated: 2015-09-18
Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients
CompletedNCT01416402
Start: 2011-08-31End: 2011-10-31Updated: 2015-04-03
Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout
CompletedNCT02252835
Start: 2014-08-01End: 2014-12-01Updated: 2026-09-18